Modern Health closes $31 Mn funding led by John Doerr & Founders Fund
Date: 2020-01-16   Author: Pankaj Singh  Category: #news

Modern Health closes $31 Mn funding led by John Doerr & Founders Fund

Modern Health, a startup company based in San Francisco, offering a comprehensive mental health platform for corporate employees, has recently closed a $31 Mn Series B funding round. It was led by Founders Fund and John Doerr, besides Afore Capital and Kleiner Perkins. As the company’s second funding round in the past year, it brings Modern Health’s total funding  to $42 Mn. Oscar winner Jared Leto and Y Combinator are among previous investors.

The mental healthcare platform of Modern Health  spans 60 countries and is used by clients including Nextdoor, Pixar, and Gitlab. The platform offers therapy sessions, guided meditations, psychological assessments, and career coaching.

Companies in America face several cases of employee burnout, leading to a revenue losses of over $190 Bn, each year. Corporate leaders are investing heavily on preventive measures to tackle issues arising out of stress and other factors common in workplaces.

Alyson Friedensohn, Modern Health’s CEO, noticed the need to provide active and timely mental healthcare to employees while working  with benefits provider known as Collective Health. Unlike competitors like Talkspace, Modern Health caters to corporate employees rather than individual clients, before they get to the psychological crisis mode, with strong ROI for employers.

Modern Health’s current 40-strong workforce is expected to double in size by 2021 as the company is continuously accelerating product developments, designs, and marketing departments.

The announcement comes along the heels of several allegations and a lawsuit filed in November 2019 by former cofounder and CTO Erica Johnson regarding the corrupted nature and equity kickbacks of Modern Health, questioning the company under the leadership of Ms. Friedensohn.

Ms. Friedensohn has denied these negative claims, stating that no employee losses have been observed since Johnson left in September.

Investors are aware of the pending lawsuit. However, they decided to continue their investment and declined to comment on Johnson’s allegations. They believed that it is going to be one of the 2020s’ most beneficial  facilities offered by any company. Founders Fund Partner, Brian Singerman, further asserted that Friedensohn’s leadership is the top reason behind the investment.

Source credit:

https://www.forbes.com/sites/alexandrawilson1/2020/01/15/exclusive-on-the-heels-of-cofounder-lawsuit-modern-health-raises-31-million-in-fresh-funding/#33f17e887d51



About Author


Pankaj Singh

Pankaj Singh

Pankaj Singh Develops content for Algosonline, Market Size Forecasters, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

Read More

More from Pankaj


Post Recommendents

Ginseng Extract Market Trends with Covid-19 Impact Analysis
Author: Rahul Varpe

Global Analysis and Insights: Ginseng Extract Market

DecResearch Inc. analyses the market growth at a CAGR of 7.5% during the forecast period. As per our expert opinion, the Ginseng Extract market was valued at USD 19.5 ...


Collagen Hydrolysates Market Future Growth, Key Statistics, Regional Analysis by 2026
Author: Rahul Varpe

Global Analysis and Insights: Collagen Hydrolysates Market

DecResearch Inc. analyses the market growth at a CAGR of 7% during the forecast period. As per our expert opinion, the Collagen Hydrolysates market was valued at...


Beta Glucan Market Segmentation, Geography & Forecast to 2026
Author: Rahul Varpe

Global Analysis and Insights: Beta Glucan Market

DecResearch Inc. analyses the market growth at a CAGR of 7.2% during the forecast period. As per our expert opinion, the Beta Glucan market was valued at USD 329.4 million...